Drug Extended-Release System Utilizing Micelle Formation of Highly Water-Soluble Drugs and a Counter Polymer.

counter polymer critical micelle concentration diffusion extended drug release extended release highly water-soluble drug matrix tablet micelle formation micelles polymeric matrix tablet water-soluble drug

Journal

Molecular pharmaceutics
ISSN: 1543-8392
Titre abrégé: Mol Pharm
Pays: United States
ID NLM: 101197791

Informations de publication

Date de publication:
04 Dec 2023
Historique:
medline: 5 12 2023
pubmed: 13 11 2023
entrez: 13 11 2023
Statut: ppublish

Résumé

The objective of this study is to clarify the mechanism of extending release of highly water-soluble drugs via counter polymer (CP) utilization in poly(ethylene oxide) (PEO)/polyethylene glycol (PEG) matrix tablets. Carbomer, poly(acrylic acid), was used as a CP, which has the opposite charges to the drugs. The in vitro release of several highly water-soluble drugs from PEO/PEG tablet with or without CP were tested, the relationship between the sustained release effect by a CP (SRE) and the physicochemical properties of the drugs was investigated. The results demonstrated that the utilization of CP can extend the release of some highly water-soluble drugs by effectively controlling the drug diffusion through matrices. On the other hand, the effectiveness of CP was different depending on the drugs applied. There were not statistical correlations between SRE and physicochemical properties such as solubility, molecular weight, and charge intensity of the drugs, while a micelle forming property of the drugs played an important role in SRE by CP. It was concluded that CP, Carbomer, having negative charges could effectively interact with opposite charges on the surface of stable drug micelles, which could result in a significant decrease in drug diffusion leading to extended drug release. It is considered that the system utilizing CP is a promising approach to achieve extended release of highly water-soluble drugs with a reasonable tablet size, especially in the case of large drug loading.

Identifiants

pubmed: 37955875
doi: 10.1021/acs.molpharmaceut.3c00377
doi:

Substances chimiques

Polymers 0
Micelles 0
Water 059QF0KO0R
Polyethylene Glycols 3WJQ0SDW1A
Tablets 0
Delayed-Action Preparations 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

6056-6065

Auteurs

Hiroyuki Kojima (H)

Pharmaceutical Research and Technology Laboratories, Astellas Pharma Inc. 180 Ozumi, Yaizu 425-0072, Shizuoka, Japan.

Takayuki Yoshida (T)

Pharmaceutical Research and Technology Laboratories, Astellas Pharma Inc. 180 Ozumi, Yaizu 425-0072, Shizuoka, Japan.

Hiromu Kondo (H)

School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-ku 422-8526, Shizuoka, Japan.

Kazuhiro Sako (K)

Pharmaceutical Research and Technology Laboratories, Astellas Pharma Inc. 180 Ozumi, Yaizu 425-0072, Shizuoka, Japan.

Articles similaires

Animals Dietary Fiber Dextran Sulfate Mice Disease Models, Animal
Vancomycin Polyesters Anti-Bacterial Agents Models, Theoretical Drug Liberation
Semiconductors Photosynthesis Polymers Carbon Dioxide Bacteria
Silicon Dioxide Water Hot Temperature Compressive Strength X-Ray Diffraction

Classifications MeSH